ERBB2 and cancer: BRCA is one of the most common cancer of the females with heterogenous pathology and broadly comprises of four subtypes, namely, luminal, basal or triple negative, HER2-enriched and normal like, which differ in the expression of hormone receptors and are prognostically different.